Samer K. Khaled - Concepedia

Author

Samer K. Khaled

Also Known As

S K Khaled, S Khaled, S. Khaled, S.K. Khaled, Samer K Khaled, Samer K. Khaled, Samer Khaled, Samira Khaled, Sheikh F Khaled

150

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

City of Hope City Of Hope National Medical Center The University of Texas MD Anderson Cancer Center Mayo Clinic in Arizona Medical College of Wisconsin

About

Samer K. Khaled is an author at City of Hope specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.3K
2	Health Sciences	8	8	977
3	Blood Transplantation	7	7	389
4	Cell Biology	3	3	142
5	Public Health	1	1	22

Samer K. Khaled

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli, The Lancet Oncology Hematological MalignancyMedicineHematologyClinical TrialsMyeloid Neoplasia	2019	465
Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL Xiuli Wang, Leslie Popplewell, Jamie R. Wagner, Blood	2016	326
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant Brenda M. Sandmaier, Samer K. Khaled, Betül Oran, American Journal of Hematology Gastric HemorrhageMixed-phenotype Acute LeukemiaImmunologyMyeloid NeoplasiaHematological Malignancy	2017	126
SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function Jie Sun, Xin He, Ying‐Hui Zhu, Cell stem cell Progenitor CellsLineage PlasticityCell RegulationMyelodysplastic Syndrome StemMedicine	2018	109
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis Sepideh Shayani, Joycelynne Palmer, Tracey Stiller, Biology of Blood and Marrow Transplantation Gvhd ProphylaxisImmunologyTransplantation MedicinePathologyActive Agvhd	2012	107
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia Anthony S. Stein, Joycelynne Palmer, Ni‐Chun Tsai, Biology of Blood and Marrow Transplantation Hematological MalignancyCell TherapyTransplantationMarrow TransplantationRadiation Therapy	2017	95
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia Xin He, Ying‐Hui Zhu, Yi‐Chun Lin, Blood	2019	91
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy Samer K. Khaled, Kathleen Claes, Yeow Tee Goh, Journal of Clinical Oncology	2022	87
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study Guillermo Garcia‐Manero, Yasmin Abaza, Koichi Takahashi, Blood Advances	2019	86
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents Ibrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, Blood Advances ImmunologyPathologyPharmacotherapyAntimicrobial ChemotherapyImmunotherapy	2019	81

Page 1